Search

Your search keyword '"Abhishek Gulati"' showing total 19 results
Start Over Author "Abhishek Gulati" Topic hepatology
19 results on '"Abhishek Gulati"'

2. Performance of a Multidisciplinary Pancreatic Cancer Conference in Predicting and Managing Resectable Pancreatic Cancer

Author

Alexander V. Kirichenko, Donald Atkinson, Harry Williams, Suzanne Morrissey, Abhijit Kulkarni, Shailendra Singh, Manav Sharma, Ghita Moussiade, Aslam Syed, Shyam Thakkar, Marcia Mitre, Bharat Rao, Mrinal Garg, Abhishek Gulati, Manish Dhawan, Amy Tang, Suzanne Schiffman, Anthony Lupetin, and Dulabh Monga

Subjects
Male, Resectable Pancreatic Cancer, medicine.medical_specialty, Pancreatic ductal adenocarcinoma, Consensus Development Conferences as Topic, Endocrinology, Diabetes and Metabolism, Stage ii, 03 medical and health sciences, Pancreatectomy, 0302 clinical medicine, Endocrinology, Pancreatic cancer, Outcome Assessment, Health Care, Internal Medicine, Carcinoma, medicine, Humans, Prospective Studies, Stage (cooking), Prospective cohort study, Aged, Hepatology, Tumor size, business.industry, Middle Aged, Prognosis, medicine.disease, Pancreatic Neoplasms, 030220 oncology & carcinogenesis, Female, 030211 gastroenterology & hepatology, Radiology, business, Carcinoma, Pancreatic Ductal
Abstract

Objectives Surgery is the curative treatment for pancreatic ductal adenocarcinoma (PDA). Guidelines recommend utilizing a multidisciplinary pancreatic cancer conference (MDPC) in treatment; however, data are limited. The objective of this study was to assess the accuracy of an MDPC. Methods Patients with PDA presented at an MDPC were prospectively collected from April 2013 to August 2016. Patients were included if the MDPC predicted them to have resectable PDA and underwent upfront surgery. Secondary aims were to compare differences in tumor characteristics, time to surgery, and resection rates with patients prior to MDPC implementation (pre-MDPC). Results A total of 278 patients were presented at the MDPC. After excluding borderline and nonresectable cases, 91 patients were predicted as resectable on evaluation, and 70 were fit for surgery. The MDPC predicted resection in 91.4%. The MDPC had larger tumor size (32.6 vs 24.0 mm), greater proportion of stage II tumor, and a shorter time from diagnosis to resection (27.3 vs 35.5 days) compared with the pre-MDPC. Microscopically negative resections were similar between MDPC and pre-MDPC (85.9% vs 88.0%) despite advanced tumor size and stage. Conclusions The MDPC demonstrates a high resection rate. Compared with a pre-MDPC, MDPC provides shorter time to surgery and selects for advanced tumors.

Published
2019
Full Text
View/download PDF

4. Immunoglobulin G4 (IgG4)-associated pouchitis – Part of IgG4 related disease? A case series and review of the literature

Author

Mohammad Bilal, Kofi Clarke, and Abhishek Gulati

Subjects
Adult, Male, medicine.medical_specialty, Referral, Colonic Pouches, Disease, Pouchitis, Inflammatory bowel disease, Autoimmune Diseases, 03 medical and health sciences, 0302 clinical medicine, Recurrence, Immunoglobulin g4, parasitic diseases, medicine, Humans, Antibiotic use, Hepatology, business.industry, General surgery, Proctocolectomy, Restorative, fungi, Gastroenterology, Endoscopy, Middle Aged, medicine.disease, Anti-Bacterial Agents, Surgery, Immunoglobulin G, 030220 oncology & carcinogenesis, Etiology, Colitis, Ulcerative, Female, 030211 gastroenterology & hepatology, IgG4-related disease, business
Abstract

Background and aims IgG4-mediated pouchitis was first described in 2011. The aetiology and pathogenesis of IgG4-associated pouchitis is unknown. Over the last four years, less than seventy cases of IgG-associated pouchitis have been reported from a pouchitis clinic in Cleveland. Methods We report the first two cases of IgG4-associated pouchitis from our inflammatory bowel disease clinic and outside of Cleveland. Conclusion This highlights the fact that this entity could be more common than we think. It is important for general gastroenterologists to think about IgG4-mediated disease if the patient has refractory pouchitis, so early diagnosis and referral can be made. This would avoid the cost of expensive therapy and minimize antibiotic use which is what happened in our cases prior to this diagnosis being made.

Published
2016
Full Text
View/download PDF

7. Performance of a Multidisciplinary Team in Predicting and Managing Resectable Pancreatic Cancer

Author

Manish Dhawan, Harry Williams, Abhijit Kulkarni, Bharat Rao, Manav Sharma, Suzanne Morrissey, Shyam Thakkar, Shailendra Singh, Abhishek Gulati, Mrinal Garg, Anthony Lupetin, Suzanne Schiffman, Marcia Mitre, Donald Atkinson, Dulabh Monga, and Alexander V. Kirichenko

Subjects
Oncology, Resectable Pancreatic Cancer, medicine.medical_specialty, Hepatology, business.industry, General surgery, Internal medicine, Gastroenterology, Medicine, business, Multidisciplinary team
Published
2017
Full Text
View/download PDF

11. Implementing a Multidisciplinary Conference Improves Patient Selection and Shortens Time to Surgery for Resectable Pancreatic Cancer

Author

Manav Sharma, Suzanne Morrissey, Manish Dhawan, Shyam Thakkar, Alexander V. Kirichenko, Abhijit Kulkarni, Shailendra Singh, Anthony Lupetin, Donald Atkinson, Dulabh Monga, Abhishek Gulati, Bharat Rao, Harry Williams, and Suzanne Schiffman

Subjects
Resectable Pancreatic Cancer, medicine.medical_specialty, Hepatology, Multidisciplinary approach, business.industry, General surgery, Gastroenterology, medicine, Time to surgery, Intensive care medicine, business, Selection (genetic algorithm)
Published
2017
Full Text
View/download PDF

14. Sa1463 The Role of Multidisciplinary Pancreatic Conference in the Management of Resectable Pancreatic Ductal Adenocarcinoma

Author

Abhijit Kulkarni, Alexander V. Kirichenko, Dulabh Monga, Suzanne Morrissey, Suzanne C. Schiffman, Mrinal Garg, Manish Dhawan, Donald Atkinson, Rishi Maheshwary, Marcia Mitre, Ujjala Kumar, Harry Williams, Abhishek Gulati, Shyam Thakkar, and Manav Sharma

Subjects
Oncology, medicine.medical_specialty, Pancreatic ductal adenocarcinoma, Hepatology, Multidisciplinary approach, business.industry, Internal medicine, Gastroenterology, medicine, business
Published
2016
Full Text
View/download PDF

15. Sa1462 The Effect of Fiducials on Resection Margin and Nodal Disease in Patients Receiving Neoadjuvant Chemoradiation Therapy for Borderline Resectable Pancreatic Adenocarcinoma

Author

Manish Dhawan, Mrinal Garg, Abhijit Kulkarni, Marcia Mitre, Abhishek Gulati, Suzanne C. Schiffman, Ujjala Kumar, Rishi Maheshwary, Suzanne Morrissey, Shyam Thakkar, Harry Williams, Manav Sharma, Donald Atkinson, Dulabh Monga, and Alexander V. Kirichenko

Subjects
Oncology, medicine.medical_specialty, Hepatology, business.industry, Gastroenterology, medicine.disease, Nodal disease, Borderline resectable, Internal medicine, medicine, Resection margin, Adenocarcinoma, In patient, Radiology, business, Fiducial marker
Published
2016
Full Text
View/download PDF

19. BUN-Creatinine Ratio Does What Glasgow-Blatchford or Other Prediction Scores Do Not: Predicts High-Risk Lesions and Endoscopic Intervention for Non-Variceal Upper GI Bleed

Author

Abhishek Gulati, Rohit Nathan, Harish Iyer, Philip O. Katz, and Anand Kumar

Subjects
medicine.medical_specialty, Creatinine, chemistry.chemical_compound, Hepatology, chemistry, business.industry, Internal medicine, Intervention (counseling), Gastroenterology, medicine, Bleed, business
Published
2013
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results